You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ACRS Exercise Disclosure
Kolbeck Roland Wilhelm · SEC Form 4 · Filed Aug 4, 2026
Exercise
Reported value range
Not reported
Kolbeck Roland Wilhelm Chief Scientific Officer
ACRS
Aclaris Therapeutics
ACRS
Transaction date
Aug 1, 2026
Public filing date
Aug 4, 2026
Filing lag
Filed 3 days later
ACRS daily price context
Close on/before transaction
$5.2
Jul 31, 2026
First close after public filing
$6.36
Aug 5, 2026
30-day return after filing
-6.45%
Through Sep 3, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 36,375 shares
- SEC ownership
- Direct
- Transaction code
- M
- Form
- 4
- Filing identifier
- 0002076327-26-000006
Filing cohort
Transactions in this filing
Showing 3 of 3
Trades
3
Issuers
1
Estimated value
$64.4K
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Aclaris Therapeutics, Inc. ACRS Current | Exercise | Aug 1, 2026 | Not reported |
| Aclaris Therapeutics, Inc. ACRS | Disposition | Aug 1, 2026 | $64.4K |
| Aclaris Therapeutics, Inc. ACRS | Exercise | Aug 1, 2026 | $0 |